This may be significant as our cohort included only patients that had whole genome sequencing as part of their clinical cancer care which tend to be patients that have failed first line chemotherapy or present with an advanced cancer.
← all excerpts
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk.
1
—
—